Ketamine in Robot-assisted Thyroidectomy
Unknown statusNot applicableNCT01997801
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
In this prospective double-blinded study, The investigators compared acute postoperative pain and rescue analgesic demand during postoperative period after robot thyroidectomy between ketamine and placebo groups.
Study details
- Official title
- The Efficacy of Intraoperative Ketamine in Patients Undergoing Robot-assisted Thyroidectomy
- Conditions
- Thyroid
- Acute Pain
- Chronic Pain
- Interventions
- Drug: Ketamine infusion
- Drug: NS infusion
- Sponsor
- Seoul National University Hospital
- Start date
- 2013-12
- Primary completion
- 2014-12
- Sex
- All
- Age range
- from 19 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients scheduled for robot-assisted thyroidectomy * ASA I-III Exclusion Criteria: * Patients with renal dysfunction * Patients with hepatic dysfunction * Patients with neurologic dysfunction * Patients with the history of drug addiction * Patients with chronic pain * Patients who are allergic to ketamine * Patients with increased ocular or intracranial pressure * Patients with the risk of aspiration
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01997801